Skip to main content
    H

    Health Catalyst Inc (HCAT)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $1.38
    -0.13 (-8.61%)

    Market Cap: $115.00M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Health Catalyst Inc (HCAT) Financials: Revenue, Profit and Cash Flow

    Updated Nov 5, 2026. Financial statements from company filings, amounts in US dollars.

    Health Catalyst reported revenue of $311.14M for the fiscal year ended Dec 31, 2025, up 1.5% from the year before. That year, net income was -$177.97M with a net margin of -57.2%, operating cash flow was $731.00K and free cash flow was -$237.00K. The quarter ended Sep 30, 2026 had revenue of $56.28M and net income of $40.50M.

    Revenue and Margins

    The operating margin was -51.7% in the fiscal year ended Dec 2025. Over the 8 years to Dec 2025, revenue grew from $73.08M, a compound annual rate of 19.9%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$311.14M+1.5%48.7%-51.7%-57.2%
    Dec 2024$306.58M+3.6%45.9%-22.8%-22.7%
    Dec 2023$295.94M+7.1%44.5%-42.9%-39.9%
    Dec 2022$276.24M+14.2%48.2%-50.7%-49.7%
    Dec 2021$241.93M+28.1%48.6%-59.4%-63.3%
    Dec 2020$188.84M+21.9%48.1%-50.9%-60.9%
    Dec 2019$154.94M+37.6%51.4%-35.4%-38.8%
    Dec 2018$112.57M+54.0%46.8%-53.4%-55.1%
    Dec 2017$73.08MN/A40.3%-62.3%-64.4%
    Annual, fiscal years ended Dec 2017 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss widened from the year before. In the quarter ended Sep 2026, net income turned positive after a loss in the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
    Revenue$311.14M$306.58M$295.94M$276.24M$241.93M$188.84M$154.94M$112.57M$73.08M
    Cost of revenue$159.46M$165.81M$164.10M$143.05M$124.35M$98.08M$75.34M$59.85M$43.64M
    Gross profit$151.68M$140.78M$131.83M$133.19M$117.57M$90.77M$79.60M$52.72M$29.44M
    Research and development$49.77M$57.95M$72.63M$75.68M$62.73M$53.52M$46.25M$38.59M$28.47M
    Operating income-$160.85M-$69.81M-$126.90M-$140.00M-$143.65M-$96.13M-$54.87M-$60.09M-$45.54M
    Net income-$177.97M-$69.50M-$118.15M-$137.40M-$153.21M-$115.02M-$60.10M-$61.98M-$47.03M
    EBITDA-$108.19M-$29.88M-$92.88M-$92.44M-$92.97M-$68.00M-$45.19M-$52.29M-$39.75M
    Fiscal years ended Dec 2017 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$56.28M$70.49M$70.76M$74.68M$76.32M$80.72M$79.41M$79.61M$76.35M$75.90M$74.72M$75.08M
    Gross profit$24.04M$34.86M$35.46M$39.38M$37.82M$38.24M$36.23M$34.69M$34.04M$35.84M$36.21M$30.51M
    Operating income$50.14M-$36.48M-$106.48M-$86.08M-$17.51M-$37.09M-$20.17M-$17.50M-$13.69M-$15.81M-$22.81M-$32.78M
    Net income$40.50M-$40.54M-$111.03M-$91.03M-$22.23M-$40.98M-$23.74M-$20.67M-$14.73M-$13.52M-$20.59M-$30.31M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, total debt of $153.25M exceeded cash and equivalents by $102.44M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
    Total assets$502.64M$858.93M$701.81M$752.29M$832.10M$577.74M$302.36M$110.97M$110.27M
    Current assets$169.31M$465.65M$393.40M$427.80M$508.39M$329.80M$264.24M$66.86M$71.39M
    Cash and equivalents$50.81M$249.65M$106.28M$116.31M$193.23M$91.95M$18.03M$28.43M$22.98M
    Total liabilities$256.86M$493.72M$334.89M$327.28M$310.00M$301.64M$101.72M$75.90M$369.74M
    Short-term debt$1.63M$231.18M$0$3.43M$4.58M$14.43M$0$3.46M$2.13M
    Long-term debt$151.62M$151.18M$228.03M$226.52M$180.94M$168.99M$48.20M$18.81M$9.62M
    Shareholder equity$245.78M$365.21M$366.92M$425.01M$522.10M$276.10M$200.64M-$374.77M-$259.48M
    Fiscal years ended Dec 2017 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$237.42M$358.60M$412.20M$502.64M$587.13M$616.18M$891.54M$858.93M$813.05M$691.72M$695.11M$701.81M
    Total liabilities$91.83M$257.78M$274.06M$256.86M$255.21M$268.63M$514.73M$493.72M$458.01M$334.72M$337.90M$334.89M
    Cash and equivalents$53.75M$60.59M$59.86M$50.81M$40.30M$50.71M$341.97M$249.65M$328.33M$201.90M$201.37M$106.28M
    Shareholder equity$145.59M$100.83M$138.15M$245.78M$331.92M$347.55M$376.81M$365.21M$355.04M$357.00M$357.21M$366.92M
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, capital expenditures exceeded operating cash flow, leaving negative free cash flow.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
    Operating cash flow$731.00K$14.56M-$33.08M-$35.27M-$23.12M-$26.15M-$32.18M-$40.30M-$36.83M
    Capital expenditures$968.00K$1.62M$1.24M$2.17M$10.45M$7.78M$2.02M$2.08M$3.34M
    Free cash flow-$237.00K$12.94M-$34.32M-$37.44M-$33.57M-$33.92M-$34.20M-$42.37M-$40.17M
    Share repurchases$5.00M$0$1.81M$8.39M$0$0$4.61M$8.71MN/A
    Investing cash flow$36.19M-$22.90M$20.29M-$39.02M-$139.68M-$82.56M-$209.60M$21.40M$22.41M
    Financing cash flow-$235.78M$151.75M$2.73M-$2.61M$264.08M$182.61M$231.38M$24.35M$24.87M
    Fiscal years ended Dec 2017 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow-$1.88M$275.00K$18.51M$9.91M-$464.00K-$9.00M$280.00K-$3.53M$6.21M$1.61M$10.27M-$19.04M
    Capital expenditures$156.00K$345.00K$338.00K$273.00K$255.00K$230.00K$670.00K$413.00K$705.00K$290.00K$208.00K$255.00K
    Free cash flow-$2.03M-$70.00K$18.17M$9.64M-$719.00K-$9.23M-$390.00K-$3.94M$5.50M$1.32M$10.06M-$19.30M
    Last 12 quarters

    Frequently Asked Questions About HCAT

    What is Health Catalyst's annual revenue?

    Health Catalyst reported revenue of $311.14M for the fiscal year ended Dec 31, 2025.

    How fast is Health Catalyst's revenue growing?

    Revenue was up 1.5% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 4.0%.

    Is Health Catalyst profitable?

    No. Health Catalyst reported net income of -$177.97M for the fiscal year ended Dec 31, 2025, with a net margin of -57.2%.

    How much free cash flow does HCAT generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $731.00K minus capital expenditures of $968.00K produced free cash flow of -$237.00K.

    How much debt does Health Catalyst have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $151.62M, short-term debt of $1.63M and cash and equivalents of $50.81M.